Research Article
Enhancement of Executive Functions but Not Memory by Multidomain Group Cognitive Training in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Multicenter Randomized Controlled Trial
Table 3
Baseline demographic, clinical, neuropsychological, and genetic characteristics of the PD-MCI study sample.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The references of the neuropsychological and clinical assessments are obtainable from the authors upon request. Values are presented as the mean ± standard deviation or median and range or frequency with percentages. For baseline comparison between groups, values of Mann–Whitney U tests, independent sample t-tests, or χ2-tests are reported as appropriate. PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale; LEDD, levodopa equivalent daily dose; APOE, apolipoprotein E; MoCA, Montreal Cognitive Assessment; SCI, subjective cognitive impairment questionnaire; BDI-II, Beck Depression Inventory II; GSE, General Self-Efficacy Questionnaire; MCI, mild cognitive impairment; an = 32; bn = 28; cself-reported activity level: 0, “not at all active;” 1, “little active;” 2, “moderate active;” 3, “very active.” |